Emergence Global Enterprises Inc. (ELOAF)

[Greensmeans]

CEN Biotech, Inc. (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 (the “Form 10-Q”) by August 15, 2022, the original due date for such filing, without unreasonable effort or expense because it requires additional time to complete its financial statements. This delay principally relates to completing the accounting process due to a new accounting system which was implemented by the Company subsequent to the end of the first fiscal quarter of 2022. The new accounting system is causing a delay in completing the financial statements because the Company, as well as its accountants are still coordinating the process through the new accounting system. The Company expects that it will file the Form 10-Q no later than the fifth calendar day following the prescribed filing date.